InvestorsHub Logo
icon url

Jimmy Joe

04/07/19 12:13 PM

#313672 RE: ARbigguy1 #313668

The increase is more than likely as a BP medication. Just gaining traction in the market over time. This would also apply to Methadone and the others as well.

P D patients would have to wait until Isradipine is approved for P D/ hypertensive patients and can be prescribed as off label is my guess.

But as you have posted, revenues are growing with respect to the generics Elite has out there.
icon url

dr_lowenstein

04/07/19 1:22 PM

#313678 RE: ARbigguy1 #313668

two points:
1. prove the increase in isradipine revenues
2. prove that the paper is being presented at AAN. (it isnt)